Enzo Biochem (FRA:EZB) FCF Margin % : -104.79% (As of Jan. 2024)

View and export this data going back to 1980. Start your Free Trial

What is Enzo Biochem FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Enzo Biochem's Free Cash Flow for the three months ended in Jan. 2024 was €-8.23 Mil. Enzo Biochem's Revenue for the three months ended in Jan. 2024 was €7.85 Mil. Therefore, Enzo Biochem's FCF Margin % for the quarter that ended in Jan. 2024 was -104.79%.

As of today, Enzo Biochem's current FCF Yield % is -86.18%.

The historical rank and industry rank for Enzo Biochem's FCF Margin % or its related term are showing as below:

FRA:EZB' s FCF Margin % Range Over the Past 10 Years
Min: -347.54 Med: -4.34 Max: 50.2
Current: -347.54

During the past 13 years, the highest FCF Margin % of Enzo Biochem was 50.20%. The lowest was -347.54%. And the median was -4.34%.

FRA:EZB's FCF Margin % is ranked worse than
86.04% of 222 companies
in the Medical Diagnostics & Research industry
Industry Median: -10.405 vs FRA:EZB: -347.54

Enzo Biochem FCF Margin % Historical Data

The historical data trend for Enzo Biochem's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enzo Biochem FCF Margin % Chart

Enzo Biochem Annual Data

Trend

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

FCF Margin %

Get a 7-Day Free Trial

-4.09

-25.45

-3.44

-61.46

-127.93

Enzo Biochem Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
FCF Margin %	Get a 7-Day Free Trial															-94.05	-35.51	89.54	-174.59	-104.79

Competitive Comparison of Enzo Biochem's FCF Margin %

For the Diagnostics & Research subindustry, Enzo Biochem's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Enzo Biochem's FCF Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Enzo Biochem's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Enzo Biochem's FCF Margin % falls into.

Enzo Biochem FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Enzo Biochem's FCF Margin for the fiscal year that ended in Jul. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Jul. 2023 )	/	Revenue (A: Jul. 2023 )
	=	-35.921	/	28.079
	=	-127.93 %

Enzo Biochem's FCF Margin for the quarter that ended in Jan. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Jan. 2024 )	/	Revenue (Q: Jan. 2024 )
	=	-8.228	/	7.852
	=	-104.79 %

Enzo Biochem FCF Margin % Related Terms

Thank you for viewing the detailed overview of Enzo Biochem's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Enzo Biochem (FRA:EZB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Enzo Biochem Inc (FRA:EZB) » Definitions » FCF Margin %

Comparable Companies

PRE DRIO PSNL AWH BIOQ MDXH OCX VNRX BIAF TTOO TMO DHR IQV XSWX:LONN IDXX A MTD ICLR ILMN WAT

Traded in Other Exchanges

ENZ:USA

Address

527 Madison Avenue, New York, NY, USA, 10022

Website

https://www.enzo.com

Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. It focuses on delivering and applying its technology to produce products and services to allow its customers to meet their clinical needs. The company has Enzo clinical labs, Enzo life sciences, Enzo therapeutics operating segments. It derives the majority of its revenues from the Clinical lab's segment.

Enzo Biochem (FRA:EZB) Headlines

No Headlines